SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-043352
Filing Date
2024-11-01
Accepted
2024-11-01 16:55:34
Documents
18
Period of Report
2024-10-25
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39662
2 ex3-1.htm EX-3.1 886
3 ex99-1.htm EX-99.1 14509
4 ex3-1_001.jpg GRAPHIC 1392294
5 ex99-1_001.jpg GRAPHIC 20053
  Complete submission text file 0001493152-24-043352.txt   2182084

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE qlgn-20241025.xsd EX-101.SCH 3009
7 XBRL LABEL FILE qlgn-20241025_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE qlgn-20241025_pre.xml EX-101.PRE 24161
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3808
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37428 | Film No.: 241419806
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)